文献
J-GLOBAL ID:201202260003804509
整理番号:12A1192287
オキサリプラチン,イリノテカン耐性大腸癌におけるEGFR関連遺伝子の変異とセツキシマブ+イリノテカンの治療効果,安全性
Prospective trial of cetuximab plus irinotecan for oxaliplatin and irinotecan-based chemotherapy-refractory patients advanced and/or metastatic colorectal cancer, evaluation of the efficacy and safety based on mutation status of the EGFR related genes
著者 (14件):
SHIMODAIRA Hideki
(Tohoku Univ.)
,
SHIMODAIRA Hideki
(Tohoku Univ Hosp)
,
SOEDA Hiroshi
(Tohoku Univ.)
,
SOEDA Hiroshi
(Tohoku Univ Hosp)
,
GAMOH Makio
(Osaki Citizen Hosp)
,
ANDOH Hideaki
(Akita Univ Graduate School of Medicine)
,
YAMAGUCHI Takuhiro
(Tohoku Univ Graduate School of Medicine)
,
WATANABE Mika
(Tohoku Univ.)
,
ISHOBE Hideki
(Yamagata Univ)
,
SUDO Tsuyoshi
(Yamagata Pref. Central Hospital)
,
KATO Shunsuke
(Tohoku Univ.)
,
KATO Shunsuke
(Tohoku Univ Hosp)
,
ISHIOKA Chikashi
(Tohoku Univ.)
,
ISHIOKA Chikashi
(Tohoku Univ Hosp)
資料名:
日本臨床腫瘍学会学術集会プログラム・抄録集
(Abstracts. Annual Meeting of Japanese Society of Medical Oncology)
巻:
10th
ページ:
167
発行年:
2012年
JST資料番号:
L7804A
資料種別:
会議録 (C)
記事区分:
会議録記事
発行国:
日本 (JPN)
言語:
英語 (EN)